AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FENNEC PHARMACEUTICALS INC. Director's Dealing 2025

Jun 4, 2025

35599_dirs_2025-06-04_3473a913-10f8-4445-96b0-ed392a1b0535.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-06-03

Reporting Person: Brughera Marco Maria (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-03	Stock Option	$7.88	A	20000	Acquired	2035-06-03	Common shares (20000)	Direct

Footnotes

F1: On June 3, 2025, Marco Brughera was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.

F2: The option is 100% vested on date of grant.